[1] Ferraci F,Bertiato G,Moretto G.Hashimoto’s encephalopathy: epidemiologic data and pathogenetic considerations[J].J Neurol Sci,2004,217(2):165-168.
[2] Ferlazzo E,Rafaele M,Mazzu I,et al.Recurrent status epilepticus as the main feature of Hashimoto’s encephalopathy[J].Epilepsy Behav,2006,8(1):328-330.
[3] Duffey P,Yee S,Reid I N, et al. Hashimoto’s encephalopathy: postmortem findings after fatal status epilepticus[J].Neurology,2003,61(8):1124-1126.
[4] Kothbauer-Marhreiter I, Sturzwneger M, Komor J, et al.Encephalopathy associated with Hashimoto thyroiditis:diagnosis and treatment[J].J Neurol,1996,243(8):585-593.
[5] Watemberg N,Greenstein D,Levine A.Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective[J].J Child Neurol,2006,21 (1):1-5.
[6] Wirkowski E,Libman R B,Batash M.Hashimoto’S encephalopathy response to intravenous immunoglobulin[J].Stroke Cerebrovasc Dis,2007,7(6):265.
[7] 姜 明,沈 扬,樊东升.桥本脑病研究进展[J].中华神经医学杂志,2008,7(5):536-537.
[8] 刘 丽,张朝东.桥本脑病的病因、临床表现和治疗[J].中华神经科杂志,2008,41(9):640-642.